Johnson SN - Search Results

1

Soluble Antigen Arrays Efficiently Deliver Peptides and Arrest Spontaneous Autoimmune Diabetes.

Firdessa-Fite R, Johnson SN, Leon MA, Khosravi-Maharlooei M, Baker RL, Sestak JO, Berkland C, Creusot RJ. Firdessa-Fite R, et al. Among authors: johnson sn. Diabetes. 2021 Jun;70(6):1334-1346. doi: 10.2337/db20-0845. Epub 2021 Jan 19. Diabetes. 2021. PMID: 33468513 Free PMC article.

2

Practical Considerations, Challenges, and Limitations of Bioconjugation via Azide-Alkyne Cycloaddition.

Pickens CJ, Johnson SN, Pressnall MM, Leon MA, Berkland CJ. Pickens CJ, et al. Among authors: johnson sn. Bioconjug Chem. 2018 Mar 21;29(3):686-701. doi: 10.1021/acs.bioconjchem.7b00633. Epub 2018 Feb 1. Bioconjug Chem. 2018. PMID: 29287474 Free PMC article. Review.

3

Antigen-Drug Conjugates as a Novel Therapeutic Class for the Treatment of Antigen-Specific Autoimmune Disorders.

Pickens CJ, Christopher MA, Leon MA, Pressnall MM, Johnson SN, Thati S, Sullivan BP, Berkland C. Pickens CJ, et al. Among authors: johnson sn. Mol Pharm. 2019 Jun 3;16(6):2452-2461. doi: 10.1021/acs.molpharmaceut.9b00063. Epub 2019 May 14. Mol Pharm. 2019. PMID: 31083955 Free PMC article.

4

Autoantigen Tetramer Silences Autoreactive B Cell Populations.

Christopher MA, Johnson SN, Griffin JD, Berkland CJ. Christopher MA, et al. Among authors: johnson sn. Mol Pharm. 2020 Nov 2;17(11):4201-4211. doi: 10.1021/acs.molpharmaceut.0c00665. Epub 2020 Oct 6. Mol Pharm. 2020. PMID: 32903002 Free PMC article.

5

Tetrameric Fluorescent Antigen Arrays for Single-Step Identification of Antigen-Specific B Cells.

Apley KD, Griffin JD, Johnson SN, Berkland CJ, DeKosky BJ. Apley KD, et al. Among authors: johnson sn. J Vis Exp. 2020 Oct 20;(164):10.3791/61827. doi: 10.3791/61827. J Vis Exp. 2020. PMID: 33165322 Free PMC article.

6

Multimeric Insulin Desensitizes Insulin-Specific B Cells.

Johnson SN, Griffin JD, Hulbert C, DeKosky BJ, Thomas JW, Berkland CJ. Johnson SN, et al. ACS Appl Bio Mater. 2020 Sep 21;3(9):6319-6330. doi: 10.1021/acsabm.0c00782. Epub 2020 Aug 11. ACS Appl Bio Mater. 2020. PMID: 35021762

7

Soluble antigen arrays improve the efficacy and safety of peptide-based tolerogenic immunotherapy.

Firdessa-Fite R, Johnson SN, Leon MA, Sestak JO, Berkland C, Creusot RJ. Firdessa-Fite R, et al. Among authors: johnson sn. bioRxiv [Preprint]. 2023 May 7:2023.05.05.539161. doi: 10.1101/2023.05.05.539161. bioRxiv. 2023. Update in: Front Immunol. 2024 Jun 12;15:1258369. doi: 10.3389/fimmu.2024.1258369 PMID: 37205572 Free PMC article. Updated. Preprint.

8

Multivalent Scaffolds to Promote B cell Tolerance.

Johnson SN, Brucks SD, Apley KD, Farrell MP, Berkland CJ. Johnson SN, et al. Mol Pharm. 2023 Aug 7;20(8):3741-3756. doi: 10.1021/acs.molpharmaceut.3c00039. Epub 2023 Jul 6. Mol Pharm. 2023. PMID: 37410969 Review.

9

Optimized Production of Fc Fusion Proteins by Sortase Enzymatic Ligation.

Apley KD, Laflin AD, Johnson SN, Batrash N, Griffin JD, Berkland CJ, DeKosky BJ. Apley KD, et al. Among authors: johnson sn. Ind Eng Chem Res. 2021 Dec 1;60(47):16839-16853. doi: 10.1021/acs.iecr.1c02842. Epub 2021 Nov 18. Ind Eng Chem Res. 2021. PMID: 38646185 Free PMC article.

10

Soluble antigen arrays provide increased efficacy and safety over free peptides for tolerogenic immunotherapy.

Firdessa-Fite R, Johnson SN, Bechi Genzano C, Leon MA, Ku A, Ocampo Gonzalez FA, Milner JD, Sestak JO, Berkland C, Creusot RJ. Firdessa-Fite R, et al. Among authors: johnson sn. Front Immunol. 2024 Jun 12;15:1258369. doi: 10.3389/fimmu.2024.1258369. eCollection 2024. Front Immunol. 2024. PMID: 38933266 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

121 results

Search Page

Filters